DNA Group (T.R.) Ltd. engages in investing in biomedical companies and real estate. Through its portfolio companies, it provides ultrasound systems for diagnosing bone strength and density and monitoring calcium leakage, as well as oral drugs for the treatment of osteoporosis. The company was founded on October 24, 2004 and is headquartered in Tel Aviv, Israel.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company